Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q42938752)
Watch
English
Selectively targeting mutant BRAF in thyroid cancer
scientific article published on January 2010
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
2805482
retrieved
11 November 2017
editorial
0 references
title
Selectively targeting mutant BRAF in thyroid cancer
(English)
1 reference
stated in
Europe PubMed Central
PMCID
2805482
retrieved
11 November 2017
author name string
Douglas W Ball
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
2805482
retrieved
11 November 2017
language of work or name
English
0 references
publication date
1 January 2010
1 reference
stated in
Europe PubMed Central
PMCID
2805482
retrieved
11 November 2017
published in
The Journal of Clinical Endocrinology and Metabolism
1 reference
stated in
Europe PubMed Central
PMCID
2805482
retrieved
11 November 2017
volume
95
1 reference
stated in
Europe PubMed Central
PMCID
2805482
retrieved
11 November 2017
issue
1
1 reference
stated in
Europe PubMed Central
PMCID
2805482
retrieved
11 November 2017
page(s)
60-61
1 reference
stated in
Europe PubMed Central
PMCID
2805482
retrieved
11 November 2017
cites work
Targeting the RAF-MEK-ERK pathway in cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805482
retrieved
27 May 2018
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805482
retrieved
27 May 2018
Phase II trial of sorafenib in advanced thyroid cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805482
retrieved
27 May 2018
BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805482
retrieved
27 May 2018
Selective growth inhibition in BRAF mutant thyroid cancer by the mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805482
retrieved
27 May 2018
BRAF mutation predicts sensitivity to MEK inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805482
retrieved
27 May 2018
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805482
retrieved
27 May 2018
Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805482
retrieved
27 May 2018
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805482
retrieved
16 August 2018
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2805482
retrieved
16 August 2018
BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20056810
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
BRAF Mutation in Papillary Thyroid Carcinoma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20056810
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1210/JC.2009-2332
1 reference
stated in
Europe PubMed Central
PMCID
2805482
retrieved
11 November 2017
PMCID
2805482
1 reference
stated in
Europe PubMed Central
PMCID
2805482
retrieved
11 November 2017
PubMed ID
20056810
1 reference
stated in
Europe PubMed Central
PMCID
2805482
retrieved
11 November 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
